Session Information
Date: Monday, November 9, 2015
Session Type: ACR Poster Session B
Session Time: 9:00AM-11:00AM
Background/Purpose: During the last decade there is evidence of a rising improvement regarding the long-term outcome of patients with Juvenile Idiopathic Arthritis (JIA). The aim of the study was to compare long-term outcome between patients with disease onset before and after 2000.
Methods: Patients (pts) > 18 years with an established JIA, a disease onset >5 years and no history of > 6 months care from external rheumatologists, were enrolled in the study. Clinical, laboratory and radiographic examination were performed at the last follow-up visit, 17.2 years post-diagnosis. The outcome variables were: radiographic damage assessed by the Total modified Sharp/van der Heijde Score (TmSvdHS), articular and extra-articular damage by Juvenile Arthritis Damage Index (JADI-A and JADI-E) and physical ability by the Health Assessment Questionnaire-Disability Index (HAQ-DI). In the multivariate analysis, possible explanatory variables were characteristics present at onset and active disease duration within 5 years of onset.
Results: A total of 102 (72 F) pts were enrolled. The age at disease onset (mean ±SD) was 7.7 ±4 yrs, the interval from onset to last visit 17.2 ±6.7 yrs and the pts’ current age 25 ±5.9 yrs. Twenty eight patients were diagnosed after 2000 (Group 1) and 74 patients before 2000 (Group 2). The 2 Groups didn’t differ in demographic and clinical characteristics, as gender, type of disease onset and ACPA positivity. At the last follow-up visit, Group 1 had better TmSvdHS, better JADI-A and better JADI-E score as compared to Group 2 (p<0.001, p<0.001, p=0.003, respectively). In contrast, HAQ-DI score did not differ between the 2 Groups (p=0.55). Disease duration within 5 yrs of onset was longer in Group 2 (p=0.02). In the multivariate analysis, disease duration within 5 yrs of onset was a prognostic factor for joint damage [B (95%CI) 2.114 (0.206,4.022), p=0.03], cumulative % time spent in a state of active disease [B (95%CI) 0.007 (0.004,0.011), p<0.001] and cumulative time spent in a state of clinical remission off medication over the entire disease course [B (95%CI) -0.667 (-1.048,-0.286), p=0.001].
Conclusion: Patients diagnosed after 2000, had a better long term outcome as compared to those before 2000. Despite the difference in disease duration, active disease duration within 5 years of onset proved to be a critical prognostic factor, probably reflecting the availability of biologics nowadays and the treat-to-target strategies.
To cite this abstract in AMA style:
Dimopoulou D, Trachana M, Pratsidou-Gertsi P, Sidiropoulos P, Theodoridou A, Kanakoudi-tsakalidou F, Garyfallos A. Improvement of the Long-Term Outcome in Greek Adult Patients with Juvenile Idiopathic Arthritis in the 21st Century [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/improvement-of-the-long-term-outcome-in-greek-adult-patients-with-juvenile-idiopathic-arthritis-in-the-21st-century/. Accessed .« Back to 2015 ACR/ARHP Annual Meeting
ACR Meeting Abstracts - https://acrabstracts.org/abstract/improvement-of-the-long-term-outcome-in-greek-adult-patients-with-juvenile-idiopathic-arthritis-in-the-21st-century/